Riley Antony A 4
4 · Forte Biosciences, Inc. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Riley Antony A
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2025-07-01$12.44/sh−134$1,667→ 31,599 total - Exercise/Conversion
Common Stock
2025-07-01+375→ 31,733 total - Exercise/Conversion
Restricted Stock Units
2025-07-01−375→ 2,250 total→ Common Stock (375 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Forte Biosciences, Inc. (the "Issuer") Common Stock.
- [F2]Includes 140 shares of Common Stock acquired July 1, 2025 under Forte Biosciences, Inc.'s 2017 Employee Stock Purchase Plan.
- [F3]Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, "Quarterly Vesting Date" with respect to any calendar year means January 1, April 1, July 1, and October 1.